|
2024-12-06 |
2024-12-04 |
S
Sale
|
Mitchell Essex D
Chief Operating Officer
Officer
|
24,856
-47.1%
76.34
USD 1,897,482
|
24,856
-47.1%
|
76.34
|
USD 1,897,482
|
|
|
2024-09-03 |
2024-08-29 |
PS
Planned sale
|
Oberton Karleen Marie
Chief Financial Officer
Officer
|
52,679
-38.5%
80.56
USD 4,243,662
|
52,679
-38.5%
|
80.56
|
USD 4,243,662
|
|
|
2024-08-08 |
2024-08-06 |
S
Sale
|
Schnittker Brandon
Div. President, GYN Surgical
Officer
|
476
-11.3%
83.11
USD 39,559
|
476
-11.3%
|
83.11
|
USD 39,559
|
|
|
2024-08-05 |
2024-08-01 |
PS
Planned sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
5,093
-32.7%
81.99
USD 417,570
|
5,093
-32.7%
|
81.99
|
USD 417,570
|
|
|
2024-08-01 |
2024-07-30 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
20,228
-1.7%
82.32
USD 1,665,169
|
20,228
-1.7%
|
82.32
|
USD 1,665,169
|
|
|
2024-08-01 |
2024-07-30 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
16,177
-1.4%
81.44
USD 1,317,455
|
16,177
-1.4%
|
81.44
|
USD 1,317,455
|
|
|
2024-08-01 |
2024-07-30 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
7,634
-0.6%
80.60
USD 615,300
|
7,634
-0.6%
|
80.60
|
USD 615,300
|
|
|
2024-07-19 |
2024-07-17 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
3,672
-0.3%
80.13
USD 294,223
|
3,672
-0.3%
|
80.13
|
USD 294,223
|
|
|
2024-07-19 |
2024-07-17 |
PS
Planned sale
|
Stamoulis Christiana
Non-Executive Director
|
9,039
-16.6%
79.50
USD 718,601
|
9,039
-16.6%
|
79.50
|
USD 718,601
|
|
|
2024-03-15 |
2024-03-14 |
S
Sale
|
GARRETT SCOTT T
Non-Executive Director
|
16,441
-25.3%
75.50
USD 1,241,296
|
16,441
-25.3%
|
75.50
|
USD 1,241,296
|
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
Dockendorff Charles J
Non-Executive Director
|
1,465
-48.2%
76.21
USD 111,648
|
1,465
-48.2%
|
76.21
|
USD 111,648
|
|
|
2024-03-11 |
2024-03-08 |
S
Sale
|
CRAWFORD SALLY
Non-Executive Director
|
9,039
-6.4%
76.40
USD 690,607
|
9,039
-6.4%
|
76.40
|
USD 690,607
|
|
|
2024-01-30 |
2024-01-29 |
PS
Planned sale
|
Oberton Karleen Marie
Chief Financial Officer
Officer
|
14,940
-12.6%
75.00
USD 1,120,500
|
14,940
-12.6%
|
75.00
|
USD 1,120,500
|
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
Dockendorff Charles J
Non-Executive Director
|
16,017
-91.6%
72.00
USD 1,153,224
|
16,017
-91.6%
|
72.00
|
USD 1,153,224
|
|
|
2023-12-13 |
2023-12-11 |
S
Sale
|
GARRETT SCOTT T
Non-Executive Director
|
10,000
-17.5%
68.71
USD 687,116
|
10,000
-17.5%
|
68.71
|
USD 687,116
|
|
|
2023-12-01 |
2023-11-29 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
47,711
-3.7%
70.41
USD 3,359,188
|
47,711
-3.7%
|
70.41
|
USD 3,359,188
|
|
|
2023-11-24 |
2023-11-21 |
S
Sale
|
Mitchell Essex D
Div. President, GYN Surgical
Officer
|
7,500
-36.9%
71.85
USD 538,890
|
7,500
-36.9%
|
71.85
|
USD 538,890
|
|
|
2023-06-20 |
2023-06-15 |
S
Sale
|
GARRETT SCOTT T
Non-Executive Director
|
10,000
-14.9%
79.72
USD 797,240
|
10,000
-14.9%
|
79.72
|
USD 797,240
|
|
|
2023-05-09 |
2023-05-05 |
PS
Planned sale
|
Mitchell Essex D
Div. President, GYN Surgical
Officer
|
2,390
-24.9%
83.73
USD 200,115
|
2,390
-24.9%
|
83.73
|
USD 200,115
|
|
|
2023-02-09 |
2023-02-07 |
PS
Planned sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
9,128
-39.0%
85.28
USD 778,445
|
9,128
-39.0%
|
85.28
|
USD 778,445
|
|
|
2022-12-16 |
2022-12-14 |
S
Sale
|
Hellmann Elisabeth A
SVP, Human Resources
Officer
|
1,649
-16.2%
76.40
USD 125,984
|
1,649
-16.2%
|
76.40
|
USD 125,984
|
|
|
2022-12-02 |
2022-11-30 |
S
Sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
12,501
-0.5%
76.02
USD 950,326
|
12,501
-0.5%
|
76.02
|
USD 950,326
|
|
|
2022-12-02 |
2022-11-30 |
S
Sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
20,999
-0.9%
75.43
USD 1,584,039
|
20,999
-0.9%
|
75.43
|
USD 1,584,039
|
|
|
2022-11-17 |
2022-11-15 |
S
Sale
|
Thornal Kevin R
Group Pres, Global Diagnostics
Officer
|
12,490
-16.7%
75.30
USD 940,509
|
12,490
-16.7%
|
75.30
|
USD 940,509
|
|
|
2022-11-17 |
2022-11-15 |
S
Sale
|
Thornal Kevin R
Group Pres, Global Diagnostics
Officer
|
6,628
-9.6%
75.37
USD 499,552
|
6,628
-9.6%
|
75.37
|
USD 499,552
|
|
|
2022-11-16 |
2022-11-14 |
S
Sale
|
Griffin John M.
General Counsel
Officer
|
3,268
-1.9%
76.49
USD 249,979
|
3,268
-1.9%
|
76.49
|
USD 249,979
|
|
|
2022-11-16 |
2022-11-14 |
S
Sale
|
Griffin John M.
General Counsel
Officer
|
23,634
-12.1%
76.07
USD 1,797,909
|
23,634
-12.1%
|
76.07
|
USD 1,797,909
|
|
|
2022-11-14 |
2022-11-11 |
S
Sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
42,893
-1.7%
75.94
USD 3,257,294
|
42,893
-1.7%
|
75.94
|
USD 3,257,294
|
|
|
2022-11-14 |
2022-11-11 |
S
Sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
52,529
-2.1%
75.57
USD 3,969,564
|
52,529
-2.1%
|
75.57
|
USD 3,969,564
|
|
|
2022-11-14 |
2022-11-11 |
S
Sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
43,000
-1.7%
75.64
USD 3,252,520
|
43,000
-1.7%
|
75.64
|
USD 3,252,520
|
|
|
2022-11-03 |
2022-11-01 |
PS
Planned sale
|
Oberton Karleen Marie
Chief Financial Officer
Officer
|
14,545
-10.3%
72.50
USD 1,054,513
|
14,545
-10.3%
|
72.50
|
USD 1,054,513
|
|
|
2022-05-19 |
2022-05-17 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
3,844
-22.1%
78.75
USD 302,730
|
3,844
-22.1%
|
78.75
|
USD 302,730
|
|
|
2022-05-19 |
2022-05-17 |
S
Sale
|
Verstreken Jan
Group President, International
Officer
|
6,500
-9.2%
78.80
USD 512,168
|
6,500
-9.2%
|
78.80
|
USD 512,168
|
|
|
2022-05-17 |
2022-05-13 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
3,842
-22.1%
75.49
USD 290,033
|
3,842
-22.1%
|
75.49
|
USD 290,033
|
|
|
2022-05-17 |
2022-05-13 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
3,210
-19.2%
75.49
USD 242,333
|
3,210
-19.2%
|
75.49
|
USD 242,333
|
|
|
2022-05-05 |
2022-05-03 |
PS
Planned sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
2,178
-13.9%
74.18
USD 161,564
|
2,178
-13.9%
|
74.18
|
USD 161,564
|
|
|
2022-02-28 |
2022-02-24 |
S
Sale
|
Daugherty Sean S.
Group President, BSH & Surg.
Officer
|
2,179
-4.3%
71.14
USD 155,016
|
2,179
-4.3%
|
71.14
|
USD 155,016
|
|
|
2021-11-23 |
2021-11-19 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
2,570
-14.1%
75.79
USD 194,791
|
2,570
-14.1%
|
75.79
|
USD 194,791
|
|
|
2021-05-12 |
2021-05-10 |
S
Sale
|
Daugherty Sean S.
Group President, BSH & Surg.
Officer
|
4,001
-13.1%
65.02
USD 260,149
|
4,001
-13.1%
|
65.02
|
USD 260,149
|
|
|
2021-02-09 |
2021-02-05 |
S
Sale
|
Bebo Allison P
SVP, Human Resources
Officer
|
6,100
-14.6%
84.06
USD 512,778
|
6,100
-14.6%
|
84.06
|
USD 512,778
|
|
|
2021-02-08 |
2021-02-04 |
PS
Planned sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
8,396
-33.5%
84.31
USD 707,867
|
8,396
-33.5%
|
84.31
|
USD 707,867
|
|
|
2020-12-14 |
2020-12-10 |
S
Sale
|
Thornal Kevin R
Div. President, Diagnostics
Officer
|
9,236
-21.8%
73.99
USD 683,409
|
9,236
-21.8%
|
73.99
|
USD 683,409
|
|
|
2020-12-14 |
2020-12-10 |
S
Sale
|
Thornal Kevin R
Div. President, Diagnostics
Officer
|
7,633
-18.7%
74.00
USD 564,804
|
7,633
-18.7%
|
74.00
|
USD 564,804
|
|
|
2020-12-14 |
2020-12-10 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
1,477
-8.2%
73.64
USD 108,759
|
1,477
-8.2%
|
73.64
|
USD 108,759
|
|
|
2020-11-20 |
2020-11-18 |
S
Sale
|
Griffin John M.
General Counsel
Officer
|
11,579
-7.9%
71.35
USD 826,208
|
11,579
-7.9%
|
71.35
|
USD 826,208
|
|
|
2020-11-20 |
2020-11-18 |
S
Sale
|
Griffin John M.
General Counsel
Officer
|
11,321
-7.2%
70.80
USD 801,482
|
11,321
-7.2%
|
70.80
|
USD 801,482
|
|
|
2020-11-19 |
2020-11-17 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
5,000
-21.5%
72.58
USD 362,900
|
5,000
-21.5%
|
72.58
|
USD 362,900
|
|
|
2020-11-16 |
2020-11-12 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
6,542
-26.0%
70.60
USD 461,846
|
6,542
-26.0%
|
70.60
|
USD 461,846
|
|
|
2020-11-06 |
2020-11-04 |
PS
Planned sale
|
Stamoulis Christiana
Non-Executive Director
|
11,146
-22.1%
74.00
USD 824,804
|
11,146
-22.1%
|
74.00
|
USD 824,804
|
|
|
2020-09-23 |
2020-09-21 |
PS
Planned sale
|
Oberton Karleen Marie
Chief Financial Officer
Officer
|
15,000
-34.1%
62.50
USD 937,500
|
15,000
-34.1%
|
62.50
|
USD 937,500
|
|
|
2020-08-05 |
2020-08-03 |
PS
Planned sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
2,617
-13.5%
71.23
USD 186,409
|
2,617
-13.5%
|
71.23
|
USD 186,409
|
|
|
2020-08-05 |
2020-08-03 |
PS
Planned sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
369
-1.9%
71.22
USD 26,280
|
369
-1.9%
|
71.22
|
USD 26,280
|
|
|
2020-08-05 |
2020-08-03 |
PS
Planned sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
1,938
-10.4%
71.27
USD 138,121
|
1,938
-10.4%
|
71.27
|
USD 138,121
|
|
|
2020-07-02 |
2020-06-30 |
PS
Planned sale
|
Valenti Peter J. III
Division Pres., Breast Health
Officer
|
10,493
-14.9%
54.07
USD 567,357
|
10,493
-14.9%
|
54.07
|
USD 567,357
|
|
|
2020-05-27 |
2020-05-22 |
S
Sale
|
Valenti Peter J. III
Division Pres., Breast Health
Officer
|
10,493
-14.9%
51.82
USD 543,779
|
10,493
-14.9%
|
51.82
|
USD 543,779
|
|
|
2020-05-27 |
2020-05-22 |
S
Sale
|
CRAWFORD SALLY
Non-Executive Director
|
31,950
-20.1%
51.99
USD 1,661,081
|
31,950
-20.1%
|
51.99
|
USD 1,661,081
|
|
|
2020-05-19 |
2020-05-15 |
S
Sale
|
Thornal Kevin R
Div. President, Diagnostics
Officer
|
13,888
-44.9%
51.51
USD 715,426
|
13,888
-44.9%
|
51.51
|
USD 715,426
|
|
|
2020-05-15 |
2020-05-13 |
S
Sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
190,996
-10.0%
50.97
USD 9,735,257
|
190,996
-10.0%
|
50.97
|
USD 9,735,257
|
|
|
2020-04-30 |
2020-04-28 |
PS
Planned sale
|
Griffin John M.
General Counsel
Officer
|
2,133
-2.2%
50.00
USD 106,650
|
2,133
-2.2%
|
50.00
|
USD 106,650
|
|
|
2020-04-30 |
2020-04-28 |
PS
Planned sale
|
Griffin John M.
General Counsel
Officer
|
2,773
-2.8%
50.00
USD 138,650
|
2,773
-2.8%
|
50.00
|
USD 138,650
|
|
|
2020-03-11 |
2020-03-09 |
PS
Planned sale
|
CRAWFORD SALLY
Non-Executive Director
|
7,846
-4.7%
44.29
USD 347,523
|
7,846
-4.7%
|
44.29
|
USD 347,523
|
|
|
2020-03-11 |
2020-03-09 |
PS
Planned sale
|
CRAWFORD SALLY
Non-Executive Director
|
3,300
-1.9%
43.57
USD 143,794
|
3,300
-1.9%
|
43.57
|
USD 143,794
|
|
|
2020-02-05 |
2020-02-03 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
194,396
-10.3%
53.54
USD 10,407,184
|
194,396
-10.3%
|
53.54
|
USD 10,407,184
|
|
|
2020-01-15 |
2020-01-13 |
PS
Planned sale
|
Griffin John M.
General Counsel
|
11,092
-10.4%
52.78
USD 585,402
|
11,092
-10.4%
|
52.78
|
USD 585,402
|
|
|
2020-01-15 |
2020-01-13 |
PS
Planned sale
|
Griffin John M.
General Counsel
|
8,532
-8.2%
52.97
USD 451,932
|
8,532
-8.2%
|
52.97
|
USD 451,932
|
|
|
2020-01-06 |
2020-01-02 |
PS
Planned sale
|
Oberton Karleen Marie
Chief Financial Officer
|
5,973
-17.1%
51.85
USD 309,694
|
5,973
-17.1%
|
51.85
|
USD 309,694
|
|
|
2020-01-06 |
2020-01-02 |
PS
Planned sale
|
Oberton Karleen Marie
Chief Financial Officer
|
10,375
-22.9%
51.66
USD 535,993
|
10,375
-22.9%
|
51.66
|
USD 535,993
|
|
|
2019-12-05 |
2019-12-04 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
4,379
-19.4%
52.12
USD 228,225
|
4,379
-19.4%
|
52.12
|
USD 228,225
|
|
|
2019-11-26 |
2019-11-22 |
S
Sale
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Officer
|
4,400
-19.1%
50.09
USD 220,400
|
4,400
-19.1%
|
50.09
|
USD 220,400
|
|
|
2019-11-26 |
2019-11-22 |
S
Sale
|
Stamoulis Christiana
Non-Executive Director
|
12,306
-24.9%
49.75
USD 612,224
|
12,306
-24.9%
|
49.75
|
USD 612,224
|
|
|
2019-11-13 |
2019-11-11 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
126,956
-7.4%
46.16
USD 5,859,908
|
126,956
-7.4%
|
46.16
|
USD 5,859,908
|
|
|
2019-11-13 |
2019-11-11 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
67,440
-3.8%
45.44
USD 3,064,743
|
67,440
-3.8%
|
45.44
|
USD 3,064,743
|
|
|
2019-09-05 |
2019-09-03 |
PS
Planned sale
|
Valenti Peter J. III
Division Pres., Breast Health
|
7,766
-13.4%
49.14
USD 381,621
|
7,766
-13.4%
|
49.14
|
USD 381,621
|
|
|
2019-08-07 |
2019-08-05 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
81,945
-4.9%
49.26
USD 4,036,938
|
81,945
-4.9%
|
49.26
|
USD 4,036,938
|
|
|
2019-08-07 |
2019-08-05 |
PS
Planned sale
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Executive Director
|
112,451
-6.3%
48.41
USD 5,444,090
|
112,451
-6.3%
|
48.41
|
USD 5,444,090
|
|
